XML 21 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income (loss) $ 15,105 $ (18,114)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 27,897 25,856
Interest expense related to amortization of debt issue costs and debt discount 1,184 5,042
Stock-based compensation 1,521 1,339
Deferred income taxes 8,643 477
Tax benefit from exercise of stock appreciation rights and vesting of restricted stock (97) 0
Net loss (gain) on disposition of property, plant and equipment (46) 113
Loss on sale of discontinued operations, net of income taxes 3,040 241
Net loss of unconsolidated joint ventures 26 234
Decrease in trade receivables 33,538 28,347
Increase in inventories (4,066) (10,628)
Decrease in accounts payable and accrued liabilities (36,372) (47,580)
Other changes in operating assets and liabilities, net (6,025) (8,769)
Net cash provided by (used in) operating activities 44,348 (23,442)
Cash flows from investing activities:    
Business acquisitions, net of cash acquired (96,457) (1,200)
Investments in unconsolidated joint ventures 0 (125)
Purchase of property, plant and equipment (20,882) (17,474)
Proceeds from disposition of property, plant and equipment 404 640
Net decrease (increase) in long-term receivables and deposits (1,729) 3,650
Net change in other assets (3,817) (344)
Net cash used in investing activities (122,481) (14,853)
Cash flows from financing activities:    
Net proceeds from issuance of long-term debt 0 414,675
Payments on long-term debt (5,874) (448,736)
Dividends paid to non-controlling interest in consolidated subsidiary (735) (927)
Employee stock purchases 539 464
Tax benefit from exercise of stock appreciation rights and vesting of restricted stock 97 0
Net cash provided by (used in) financing activities (5,973) (34,524)
Net increase (decrease) in cash and cash equivalents (84,106) (72,819)
Cash and cash equivalents, beginning of period 142,597 152,542
Cash and cash equivalents, end of period $ 58,491 $ 79,723